Precipio, Inc - נכסים נקיים למניה בודדת PRPO

The visualization of book value per share demonstrates the impact of insurance limits on test costs. Proprietary consumables and recurring revenue ensure business stability. Precipio, Inc. generates revenue from expert blood analyses for oncology clinics. The value of 8.32 shapes the current metric, allowing for a real-time assessment of the actual capital of Precipio, Inc. net of all liabilities.

Investors are evaluating the potential of Precipio, Inc. (PRPO) through the price-to-book ratio, where the book value per share reflects the portion of equity attributable to a single security after deducting all liabilities. By analyzing this chart of historical book value per share, one can determine how effectively investments in the precision cancer genetic diagnostics platform are being capitalized into actual business value.